Anne-Marie Birkill is a respected company director and investor with deep expertise in science and technology ventures. As co-founder and director of OneVentures, she helps manage over $900 million in funding for tech, healthcare and science-based companies.
She sourced OneVentures’ investment in UQ spinout Vaxxas, which has since raised $300 million for its needle-free vaccine delivery platform. She also led the firm’s investment in Charm Health, later acquired by ASX-listed Citadel Group.
Birkill is a strong advocate for gender equity, mentoring women and assuming leadership roles in organisations that support women in entrepreneurship, STEM and venture capital.
She serves as a Director for UniQuest and InterFinancial Corporate Finance, and chairs the board of ASX-listed PPK Group. She also chairs the Project Investment Committee and sits on the Industry Steering Committee for the UQ-lead Trailblazer Food and Beverage Accelerator.
Previously, she was CEO of the i.lab Incubator, supporting over 100 startups.
"I love the Albert Einstein quote: ‘Anyone who has never made a mistake has never tried anything new.’ Trying new things can be frightening, but more frightening is simply standing still."
